Search
for
Sort by
Research 211–240 of 1000+
- PO.8.170 Drug-induced lupus or systemic lupus erythematosus after experimental COVID-19 therapy: difficulties in differential diagnosis
- Drug utilization pattern and adverse drug reactions of chemotherapy in pediatric patients at Muhimbili National Hospital, Tanzania
- Drug-Induced Hair Changes
- Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
- Drug Repurposing in Dermatology: Molecular Biology and Omics Approach
- Related Topic: Drug Permeation Through Hair Follicles
- A case of widespread actinic granuloma with associated drug-induced lupus erythematosus
- Mucoadhesive Polymer Hyaluronan as Biodegradable Cationic/Zwitterionic-Drug Delivery Vehicle
- O1: Contribution of in-utero drug exposure when interpreting hair results in young children
- Widespread Dystrophic-Anagen Alopecia and Drug Eruption due to Usage of PEG-IFN ?-2a /Ribavirin Combination Therapy
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Percutaneous Drug Delivery to the Hair Follicle
- Investigating drug induced alopecia
- Drug points: Remission of alopecia universalis during sulphasalazine treatment for rheumatoid arthritis
- Development and In Vitro Characterization of Neusilin® US2-Based Solid Self-Nanoemulsifying Drug Delivery System for Oral Administration of Finasteride
- The effects of androgens on drug metabolism and transport: clinical pharmacologic considerations for people assigned female at birth
- Plant‐derived nanovesicles as potential drug delivery systems for topical use: Emerging applications in dermatology and cosmetology
- Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs
- Drug‐Free Ultrasound‐Responsive Mechanoluminescent Suture Enables On‐Demand Antibacterial Therapy and Enhanced Healing of Infected Wounds
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Mechanisms and Research Advances in Drug Delivery Systems for Psoriasis and Atopic Dermatitis
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Baricitinib for Alopecia Universalis Following Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Dual-drug nanostructured lipid carriers of spironolactone and 2-deoxy-D-ribose for targeted follicular delivery in androgenetic alopecia
- Drug Repurposing: Expanding Therapeutic Potential of Existing Drugs
- Unlocking Hair Follicles as Drug Reservoirs: Advances in Transfollicular Drug Delivery
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system
- Nanotechnology-based drug formulation and delivery systems for skin medical aesthetic dermatology: mechanisms, applications, and safety
- Precision and Personalized Medicine in Transdermal Drug Delivery Systems: Integrating AI Approaches